Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$1.3 million.

  • Biomerica's Consolidated Net Income fell 3894.74% to -$1.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$4.0 million, marking a year-over-year increase of 2822.48%. This contributed to the annual value of -$5.0 million for FY2025, which is 1684.51% up from last year.
  • According to the latest figures from Q4 2025, Biomerica's Consolidated Net Income is -$1.3 million, which was down 3894.74% from $2000.0 recorded in Q3 2025.
  • In the past 5 years, Biomerica's Consolidated Net Income ranged from a high of $2000.0 in Q3 2025 and a low of -$2.1 million during Q1 2021
  • In the last 5 years, Biomerica's Consolidated Net Income had a median value of -$1.5 million in 2023 and averaged -$1.4 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first plummeted by 148397.97% in 2023, then surged by 10015.2% in 2025.
  • Over the past 5 years, Biomerica's Consolidated Net Income (Quarter) stood at -$1.1 million in 2021, then plummeted by 44.5% to -$1.6 million in 2022, then rose by 7.32% to -$1.5 million in 2023, then soared by 36.96% to -$950000.0 in 2024, then tumbled by 38.95% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q4 2025, $2000.0 for Q3 2025, and -$1.5 million during Q2 2025.